EN
HI
Vivanza Biosciences Chart
Vivanza Biosciences Share Key Metrics
Volume
12372.00
Market Cap
7.36 CR
LTQ@LTP
3290@1.81
ATP
1.84
Var Margin
25 %
Circuit Range
1.66-2.02
Delivery %
85.68 %
Value
22764.48
ASM/GSM
No
Market Lot
1
Summary
Vivanza Biosciences share price is ₹1.81 as of 21 May, 2026. The stock Vivanza Biosciences intraday movement has stayed between ₹1.81 and ₹1.98, while on a 52-week basis,Vivanza Biosciences price 52 week high is ₹2.94 & its 52 week low is ₹1.75.
In terms of trading activity, Vivanza Biosciences has recorded a volume of 12372 shares, The Vivanza Biosciences has a market cap of ₹40000000 CR. The stock’s Average Traded Price (ATP) stands at ₹1.84, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3290 @ ₹1.81.
Vivanza Biosciences operates within a circuit range of ₹1.66 – ₹2.02, with a Value of ₹22764.48. The Delivery Percentage for the day is 85.68%. Additionally, Vivanza Biosciences currently falls under the No framework, and trades with a market lot size of 1.
Vivanza Biosciences Fundamentals
View MoreP/E Ratio
18.68
P/B Ratio
1.69
Div. Yield
0
Sector P/E
41.56
Sector P/B
2.05
Sec. Div. Yield
79.53
Vivanza Biosciences Resistance and Support
Pivot 1.84
Resistance
First Resistance
1.85
Second Resistance
1.85
Third Resistance
1.86
Support
First Support
1.84
Second Support
1.83
Third Support
1.83
Vivanza Biosciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-07 | Audited Results |
| 2026-05-04 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-09-01 | Others |
| 2025-08-13 | Quarterly Results |
| 2025-05-12 | Audited Results |
| 2025-01-31 | Quarterly Results & Others |
Vivanza Biosciences News
Vivanza Biosciences Ltd - 530057 - Board Meeting Outcome for Audited Financial Results For The Quarter And Year Ended On 31St March, 2026
Vivanza Biosciences' board approved Q4 & FY26 cons. financial results, with FY26 cons. revenue at ₹115.91 crore and net profit at ₹0.39 crore, turning profitable from a loss in FY25. The board also noted the resignations of two key personnel and reconstituted its committees.
May 07 2026 22:05:00
Vivanza Biosciences Ltd - 530057 - Board Meeting Intimation for Rescheduling Of Board Meeting-Intimation Under Regulation 29 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Vivanza Biosciences rescheduled its Board Meeting for May 7, 2026, from the earlier May 4, 2026 date. The meeting will consider and approve the audited Q4 and full-year FY26 financial results.
May 04 2026 15:05:00
Read More
About Vivanza Biosciences
NSE : 0
BSE : 530057
ISIN : INE984E01035
Ivee Injectaa Limited is an existing closely-heldprofit-making Company presently engaged in the manufacture ofLarge Volume Parenterals (LVPs) with an installed capacity of 18lac units per annum at Village Sabalpur Junagadh DistrictGujarat. The Company was incorporated as Ivee Injectaa PrivateLimited on the 6th March 1982 and subsequently converted intoa Public Limited Company on the 11th May 1992.The Company now proposes to expand its existing installedcapacity to manufacture Large Volume Parenterals from 18 lacunits per annum to 54 lac units per annum and to diversify intothe manufacture of Small Volume Parenterals (SVP) with aninstalled capacity of 294 lac unit per annum.
Vivanza Biosciences Management
| Name | Position |
|---|---|
| JA Mehta | Managing Director |
| Rina Kumari | Non Executive Independent Director |
Vivanza Biosciences Similar Stocks
Svarnim Trade Udyog Ltd.
9.40
-0.30 (3.09%)
Trio Mercantile & Trading Ltd.
1.02
-0.10 (8.93%)
Nyssa Corporation Ltd.
2.50
-0.02 (0.79%)
Shyama Computronics And Services Ltd.
2.93
0.00 (0.00%)
Flora Corporation Ltd.
8.15
-0.05 (0.61%)
Centuple Global Ltd.
43.00
0.00 (0.00%)
Datiware Maritime Infra Ltd.
26.20
0.00 (0.00%)
Simplex Papers Ltd.
1640.00
41.00 (2.56%)
CHD Chemicals Ltd.
6.25
0.63 (11.21%)
Vivanza Biosciences FAQs
The Buying Price of Vivanza Biosciences share is 1.81 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Vivanza Biosciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Vivanza Biosciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Vivanza Biosciences shares is 18.68. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Vivanza Biosciences shares is 1.69. Useful to assess the stock's value relative to its book value.
To assess Vivanza Biosciences’s valuation compare Sector P/E, P/B which are 41.56 & 2.05 with sector averages, along with growth rates and financial metrics.
The Market Cap of Vivanza Biosciences is 7.36 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Vivanza Biosciences share price is 2.94 & 1.75. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Vivanza Biosciences belongs to the Miscellaneous sector.
